| Botulinum Toxin and Related Neurological Disorders | Lifetime | 109 | CA 9 | 99.21 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 139 | CA 9 | 99.31 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 201 | CA 12 | 99.29 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 16 | CA 3 | 98.81 |
| Genetic Neurodegenerative Diseases | Lifetime | 196 | CA 11 | 98.78 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 283 | CA 26 | 97.46 |
| Long-Term Effects of COVID-19 | Lifetime | 844 | CA 23 | 94.72 |
| Neuroscience and Neural Engineering | Lifetime | 842 | CA 41 | 97.11 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 176 | CA 8 | 96.68 |
| Balance, Gait, and Falls Prevention | Lifetime | 547 | CA 61 | 96.27 |
| Cerebral Palsy and Movement Disorders | Lifetime | 965 | CA 123 | 95.65 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 863 | CA 36 | 94.65 |
| Restless Legs Syndrome Research | Lifetime | 188 | CA 14 | 94.78 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 882 | CA 54 | 93.46 |
| Neurological diseases and metabolism | Lifetime | 805 | CA 31 | 91.69 |
| Neurological and metabolic disorders | Lifetime | 798 | CA 41 | 88.41 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 3 | CA 1 | 99.77 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 14 | CA 1 | 99.63 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 10 | CA 1 | 98.86 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 16 | CA 1 | 98.52 |
| Neuroscience and Neural Engineering | 2021-2025 | 66 | CA 2 | 97.71 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 53 | CA 1 | 96.28 |
| Neurological and metabolic disorders | 2021-2025 | 15 | CA 1 | 92.47 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 121 | CA 14 | 95.69 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 85 | CA 2 | 88.13 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 976 | CA 53 | 89.36 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 266 | CA 11 | 89.15 |
| Balance, Gait, and Falls Prevention | 2021-2025 | 500 | CA 35 | 87.20 |
| Restless Legs Syndrome Research | 2021-2025 | 105 | CA 3 | 86.01 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 69 | CA 3 | 83.08 |
| Cerebral Palsy and Movement Disorders | 2021-2025 | 995 | CA 83 | 83.94 |
| Spinal Dysraphism and Malformations | 2021-2025 | 247 | CA 12 | 81.31 |
| Child Abuse and Related Trauma | 2021-2025 | 103 | CA 1 | 65.81 |
| Vagus Nerve Stimulation Research | 2021-2025 | 599 | CA 14 | 63.26 |
